Amgen Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amgen (AMGN) Tops Q2 EPS by 38c, Offers FY Guidance
July 30, 2019 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $3.97, $0.38 better than the analyst estimate of $3.59. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.68 billion.
GUIDANCE:
Amgen sees FY2019 EPS of $13.75-$14.30, versus the consensus of $13.97. Amgen sees... More
